Trump Family's Drone Gambit: The Powerus Deal Decoded
On Monday morning, Aureus Greenway Holdings (Nasdaq: AGH) — a two-club Florida golf operator generating $3.3 million in annual revenue — announced an all-stock merger with Powerus, a West Palm Beach autonomous drone and defense company founded in 2025. Upon closing, expected in summer 2026, the combined entity will trade on Nasdaq as Powerus Corporation under the ticker PUSA. AGH shares surged as high as $7.73 intraday before settling at $5.48, up 12.5%. This is not a conventional acquisition. It is a reverse merger: a tiny public listing platform being reborn as a defense-autonomy story.
Who Is Powerus — And What Does It Actually Do?
Powerus was co-founded by former U.S. Army Special Operations veterans and operates through three wholly-owned subsidiaries: Kaizen Aerospace (heavy-lift drones capable of carrying industrial payloads up to 675 kg), Tandem Defense (tactical platforms), and Agile Autonomy (maritime vessel autonomy). The company claims a production ambition of over 10,000 drones per month — a scale rivaling established U.S. defense primes — and is reportedly pursuing partnerships to acquire Ukrainian battlefield drone technology and adapt it for Pentagon procurement. The U.S. Department of Defense is listed as a client, though the contractual depth of that relationship remains unverified pending SEC filings.
The Trump Network and Its Capital Architecture
Eric Trump and Donald Trump Jr. are backing the deal through American Ventures. Both brothers hold approximately 6% stakes each in Dominari Securities, the investment bank serving as placement agent for the deal's $9 million private placement at $3.00 per share. Additional investors include Unusual Machines (UMAC), a domestic drone manufacturer on whose advisory board Trump Jr. sits, and the Korea Climate & Governance Improvement Fund (KCGI), which committed a $50 million strategic investment. This is the third major drone investment by the Trump brothers in four months, following Trump Jr.'s November 2024 advisory role at UMAC and a February 2026 backing of Israeli drone maker Xtend's $1.5 billion Nasdaq-bound merger.
The Policy Tailwind Is Genuine — and Enormous
The macro setup is not hype. The Pentagon's Drone Dominance initiative targets roughly $1.1 billion in procurement of U.S.-made drone systems by 2027. Chinese drone manufacturers — including DJI — face federal bans on new procurement. President Trump has proposed a $1.5 trillion FY2027 defense budget. NATO allies have been pressured toward a 5% of GDP defense spending target by 2035. These are structural forces, not talking points, and they materially benefit credible domestic autonomy platforms.
What the Market Is Missing
Here is where professional discipline separates signal from noise. The market is pricing a narrative before the disclosure package exists. The critical document — the Form S-4 registration statement — has not been filed. Without it, investors lack the merger exchange ratio, Powerus's audited financials, pro forma cap table, backlog quality, customer concentration, and dilution terms.
AGH's legacy financials expose the shell's limits: $29.4 million cash (largely equity-financed), negative $1.5 million operating cash flow, and a $2.55 million net loss for the nine months ending September 2025. The $3.00 private placement price versus the $7.73 intraday high signals that deal insiders are accessing materially better economics than open-market buyers.
The governance overhang is institutional-grade risk. Senate Democrats have flagged that 1789 Capital — the Trump sons' venture fund — saw its portfolio companies receive over $70 million in Pentagon contracts between April and November 2025. Whether that constitutes improper influence or savvy deal-making, it caps the institutional buyer base.
The Verdict
The bull case is structurally real: right policy moment, right scarcity premium in public markets, credible dual-use technology thesis, and a powerful access network. The bear case is equally real: a sub-one-year-old company making extraordinary manufacturing claims, a reverse-merger structure prone to dilution surprises, and zero audited proof of revenue scale. Trade it on momentum if you must. Underwrite it only after the S-4 lands. The burden of proof remains heavier than the headline.
not investment advice